|
| Entrez Id: |
28 |
| Gene Symbol: |
ABO |
ABO
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.
|
22675575 |
2012 |
|
| Entrez Id: |
1636 |
| Gene Symbol: |
ACE |
ACE
|
0.010 |
GeneticVariation
|
phenotype |
LHGDN |
The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosis.
|
14691571 |
2004 |
|
| Entrez Id: |
94 |
| Gene Symbol: |
ACVRL1 |
ACVRL1
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
ADAMTS13
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Antithrombotic effect of grape seed proanthocyanidins extract in a rat model of deep vein thrombosis.
|
21095090 |
2011 |
|
| Entrez Id: |
55109 |
| Gene Symbol: |
AGGF1 |
AGGF1
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
| Entrez Id: |
183 |
| Gene Symbol: |
AGT |
AGT
|
0.010 |
GeneticVariation
|
phenotype |
LHGDN |
[Study on the association between polymorphisms in angiotensinogen gene and deep venous thrombosis].
|
18543221 |
2008 |
|
| Entrez Id: |
359 |
| Gene Symbol: |
AQP2 |
AQP2
|
0.010 |
AlteredExpression
|
phenotype |
LHGDN |
Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII.
|
18515885 |
2008 |
|
| Entrez Id: |
481 |
| Gene Symbol: |
ATP1B1 |
ATP1B1
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.
|
22675575 |
2012 |
|
| Entrez Id: |
720 |
| Gene Symbol: |
C4A |
C4A
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
| Entrez Id: |
811 |
| Gene Symbol: |
CALR |
CALR
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
| Entrez Id: |
875 |
| Gene Symbol: |
CBS |
CBS
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
| Entrez Id: |
57821 |
| Gene Symbol: |
CCDC181 |
CCDC181
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.
|
22675575 |
2012 |
|
| Entrez Id: |
6347 |
| Gene Symbol: |
CCL2 |
CCL2
|
0.200 |
Biomarker
|
phenotype |
RGD |
Effects of bone marrow-derived endothelial progenitor cell transplantation on vein microenvironment in a rat model of chronic thrombosis.
|
18167211 |
2007 |
|
| Entrez Id: |
1230 |
| Gene Symbol: |
CCR1 |
CCR1
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
| Entrez Id: |
64072 |
| Gene Symbol: |
CDH23 |
CDH23
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
| Entrez Id: |
10658 |
| Gene Symbol: |
CELF1 |
CELF1
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.
|
22675575 |
2012 |
|
| Entrez Id: |
1312 |
| Gene Symbol: |
COMT |
COMT
|
0.010 |
GeneticVariation
|
phenotype |
LHGDN |
We show that the COMT rs4680 variant modulates tHcy, and might be associated with venous thrombosis risk as well.
|
18064318 |
2007 |
|
| Entrez Id: |
1437 |
| Gene Symbol: |
CSF2 |
CSF2
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Venous thrombosis occurred in 17% of patients (concurrent v sequential GM-CSF, 29% v 5%; P2 = .08).
|
8120554 |
1994 |
|
| Entrez Id: |
1493 |
| Gene Symbol: |
CTLA4 |
CTLA4
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
| Entrez Id: |
6372 |
| Gene Symbol: |
CXCL6 |
CXCL6
|
0.200 |
Biomarker
|
phenotype |
RGD |
Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules.
|
7749835 |
1995 |
|
| Entrez Id: |
285440 |
| Gene Symbol: |
CYP4V2 |
CYP4V2
|
0.110 |
GeneticVariation
|
phenotype |
GWASDB |
Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.
|
22675575 |
2012 |
|
| Entrez Id: |
285440 |
| Gene Symbol: |
CYP4V2 |
CYP4V2
|
0.110 |
AlteredExpression
|
phenotype |
LHGDN |
Gene variants associated with deep vein thrombosis.
|
18349091 |
2008 |
|
| Entrez Id: |
2022 |
| Gene Symbol: |
ENG |
ENG
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
| Entrez Id: |
2056 |
| Gene Symbol: |
EPO |
EPO
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha.
|
12670338 |
2003 |
|
| Entrez Id: |
2056 |
| Gene Symbol: |
EPO |
EPO
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Deep vein thrombosis occurring on treatment of patients receiving thalidomide with erythropoietin.
|
17547733 |
2007 |